178 related articles for article (PubMed ID: 30814660)
1. New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma.
Verhoeven J; Hulpia F; Kersemans K; Bolcaen J; De Lombaerde S; Goeman J; Descamps B; Hallaert G; Van den Broecke C; Deblaere K; Vanhove C; Van der Eycken J; Van Calenbergh S; Goethals I; De Vos F
Sci Rep; 2019 Feb; 9(1):2878. PubMed ID: 30814660
[TBL] [Abstract][Full Text] [Related]
2. 2-[
Verhoeven J; Baguet T; Piron S; Pauwelyn G; Bouckaert C; Descamps B; Raedt R; Vanhove C; De Vos F; Goethals I
Nucl Med Biol; 2020; 82-83():9-16. PubMed ID: 31841816
[TBL] [Abstract][Full Text] [Related]
3. System L amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-L-tyrosine (FET).
Habermeier A; Graf J; Sandhöfer BF; Boissel JP; Roesch F; Closs EI
Amino Acids; 2015 Feb; 47(2):335-44. PubMed ID: 25385314
[TBL] [Abstract][Full Text] [Related]
4. Radiosynthesis and Preclinical Evaluation of
Gröner B; Hoffmann C; Endepols H; Urusova EA; Brugger M; Neumaier F; Timmer M; Neumaier B; Zlatopolskiy BD
Mol Pharm; 2024 Jun; 21(6):2795-2812. PubMed ID: 38747353
[No Abstract] [Full Text] [Related]
5. Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2.
Aoki M; Watabe T; Nagamori S; Naka S; Ikeda H; Kongpracha P; Horitsugi G; Kanai Y; Shimosegawa E; Kanai Y; Hatazawa J
Ann Nucl Med; 2019 Jun; 33(6):394-403. PubMed ID: 30820863
[TBL] [Abstract][Full Text] [Related]
6.
Liesche F; Lukas M; Preibisch C; Shi K; Schlegel J; Meyer B; Schwaiger M; Zimmer C; Förster S; Gempt J; Pyka T
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2163-2168. PubMed ID: 31289907
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
[TBL] [Abstract][Full Text] [Related]
8. Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.
Wiriyasermkul P; Nagamori S; Tominaga H; Oriuchi N; Kaira K; Nakao H; Kitashoji T; Ohgaki R; Tanaka H; Endou H; Endo K; Sakurai H; Kanai Y
J Nucl Med; 2012 Aug; 53(8):1253-61. PubMed ID: 22743251
[TBL] [Abstract][Full Text] [Related]
9. First-in-human assessment of the novel LAT1 targeting PET probe
Nozaki S; Nakatani Y; Mawatari A; Hume WE; Wada Y; Ishii A; Tanaka M; Tsuyuguchi N; Doi H; Watanabe Y
Biochem Biophys Res Commun; 2022 Mar; 596():83-87. PubMed ID: 35121373
[TBL] [Abstract][Full Text] [Related]
10. (18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.
Bolcaen J; Descamps B; Deblaere K; Boterberg T; De Vos Pharm F; Kalala JP; Van den Broecke C; Decrock E; Leybaert L; Vanhove C; Goethals I
Nucl Med Biol; 2015 Jan; 42(1):38-45. PubMed ID: 25218024
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of ¹⁸F labeled FET prodrugs for tumor imaging.
Wang L; Lieberman BP; Ploessl K; Kung HF
Nucl Med Biol; 2014 Jan; 41(1):58-67. PubMed ID: 24183614
[TBL] [Abstract][Full Text] [Related]
12.
Watabe T; Ikeda H; Nagamori S; Wiriyasermkul P; Tanaka Y; Naka S; Kanai Y; Hagiwara K; Aoki M; Shimosegawa E; Kanai Y; Hatazawa J
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):321-331. PubMed ID: 27550420
[TBL] [Abstract][Full Text] [Related]
13. Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET).
Bashir A; Mathilde Jacobsen S; Mølby Henriksen O; Broholm H; Urup T; Grunnet K; Andrée Larsen V; Møller S; Skjøth-Rasmussen J; Skovgaard Poulsen H; Law I
Neuro Oncol; 2019 Dec; 21(12):1595-1606. PubMed ID: 31618420
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of radiochemotherapy in patients with glioblastoma using O-(2-¹⁸Fluoroethyl)-L-tyrosine positron emission tomography: is dynamic imaging helpful?
Piroth MD; Liebenstund S; Galldiks N; Stoffels G; Shah NJ; Eble MJ; Coenen HH; Langen KJ
Mol Imaging; 2013 Sep; 12(6):388-95. PubMed ID: 23981784
[TBL] [Abstract][Full Text] [Related]
16. Imaging the L-type amino acid transporter-1 (LAT1) with Zr-89 immunoPET.
Ikotun OF; Marquez BV; Huang C; Masuko K; Daiji M; Masuko T; McConathy J; Lapi SE
PLoS One; 2013; 8(10):e77476. PubMed ID: 24143237
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Dynamic O-(2-[
Lohmann P; Piroth MD; Sellhaus B; Weis J; Geisler S; Oros-Peusquens AM; Mohlberg H; Amunts K; Shah NJ; Galldiks N; Langen KJ
World Neurosurg; 2018 Nov; 119():e653-e660. PubMed ID: 30077752
[TBL] [Abstract][Full Text] [Related]
18.
Nozaki S; Nakatani Y; Mawatari A; Shibata N; Hume WE; Hayashinaka E; Wada Y; Doi H; Watanabe Y
Sci Rep; 2019 Oct; 9(1):15718. PubMed ID: 31673030
[TBL] [Abstract][Full Text] [Related]
19. Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic.
Hutterer M; Ebner Y; Riemenschneider MJ; Willuweit A; McCoy M; Egger B; Schröder M; Wendl C; Hellwig D; Grosse J; Menhart K; Proescholdt M; Fritsch B; Urbach H; Stockhammer G; Roelcke U; Galldiks N; Meyer PT; Langen KJ; Hau P; Trinka E
J Nucl Med; 2017 Jan; 58(1):129-137. PubMed ID: 27469356
[TBL] [Abstract][Full Text] [Related]
20. Comparison of (18)F-FET and (18)F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma.
Nedergaard MK; Michaelsen SR; Perryman L; Erler J; Poulsen HS; Stockhausen MT; Lassen U; Kjaer A
Nucl Med Biol; 2016 Mar; 43(3):198-205. PubMed ID: 26924500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
